CLINICAL_TRIALS ClinicalTrials.gov record update

A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04198818
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:22.104467+00:00
Published At: 2024-07-19T00:00:00+00:00
Record Updated At: 2024-07-19
Results Posted At: 2024-07-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Tumors", "Melanoma", "Non-Small-Cell Lung Cancer", "Erdheim-Chester Disease", "Other RAS/RAF/MEK/ERK Mutated Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-19"
protocolSection.identificationModule.nctId: "NCT04198818"
protocolSection.identificationModule.officialTitle: "A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-07-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.